Table 1.
Names | Sequences 5′-3′ |
---|---|
CASC2-F | GCACATTGGACGGTGTTTCC |
CASC2-R | CCCAGTCCTTCACAGGTCAC |
U6-F | CTCGCTTCGGCAGCACA |
U6-R | AACGCTTCACGAATTTGCGT |
β-catenin | AAAATGGCAGTGCGTTTAG |
β-catenin | TTTGAAGGCAGTCTGTCGTA |
c-Myc-F | TGCCCATTTGGGGACACTTC |
c-Myc-R | TACGGCTGCACCGAGTCGT |
CyclinD1-F | CGCCCCACCCCTCCAG |
CyclinD1-R | CCGCCCAGACCCTCAGACT |
GAPDH-F | CGGAGTCAACGGATTTGGTCGTAT |
GAPDH-R | AGCCTTCTCCATGGTGGTGAAGAC |
IDH1-F | GCTTGTGAGTGGATGGGTAAAA |
IDH1-R | ATTGCCAACATGACTTACTTGATC |
Note: “F” and “R” represent forward and reverse primers, respectively.
Abbreviations: CASC2, cancer susceptibility candidate 2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; IDH1, isocitrate dehydrogenase 1; RT-qPCR, reverse transcription quantitative polymerase chain reaction.